Cite
HARVARD Citation
Macchia, G. et al. (2022). Efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic/persistent/recurrent ovarian cancer: a prospective, multicenter phase II study (MITO-RT3/RAD). International journal of gynecological cancer. 32 (7), pp. 939-943. [Online].